AGNC Q1 2026 Earnings Strong Earnings Beat Driven by Higher Net Interest Income and Stable Book Value Catalyst Pharmaceuticals CPRX Q1 2026 Earnings EPS Beat Signals Operational Strength Amid Quiet Revenue Reporting RARE Q1 2026 Earnings WiderthanExpected Loss as Pipeline Development Continues AEI Q1 2026 Earnings Narrowing Losses Amid Quiet Quarter SPRB Q1 2026 Earnings Narrower Than Expected Loss Drives Positive Sentiment AMSF Q1 2026 Earnings EPS Misses Expectations as Margin Pressures Mount